Smart Phone ACT Treatment for Adults With Longstanding Pain - a Pilot Study
CompletedNot applicableNCT03344926
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The aims are to test feasibility and preliminary effects of a smart phone delivered ACT treatment for adults with longstanding pain. The hypotheses are that 1. ACTsmart will be a feasible and accessable treatment delivery form 2. ACTsmart will improve function and quality of life
Study details
- Official title
- ACTsmart - Feasibility of Smart Phone Delivered ACT Treatment for Adults With Longstanding Pain
- Conditions
- Interventions
- Behavioral: ACTsmart
- Sponsor
- Rikard Wicksell
- Collaborators
- AFA Insurance
- Organization
- Karolinska Institutet
- Start date
- 2017-10-23
- Primary completion
- 2019-12-23
- Sex
- All
- Age range
- from 18 Years to 70 Years
- Results posted
- No results posted in this snapshot
- Countries
- Sweden
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * a pain duration of ≥ 6 months; * able to read and write in Swedish * have access to a smart phone with internet access * no planned changes in medication use, or any other changes in interventions for their pain planned Exclusion Criteria: * injury or illness that require immediate assessment or different treatment, or that is expected to progress significantly during the next 6 months * unstable medication (planned changes in medication during next 4 months) * ACT or CBT treatment during the past 3 months * severe psychiatric co-morbidity (e.g. high risk of suicide) as assessed by the psychologist in a semi-structured interview
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT03344926